The mitotic serine threonine kinase, Aurora-2, is a potential target for drug development in human pancreatic cancer

Sangeeta Rojanala, Haiyong Han, Rubén M. Muñoz, Walden Browne, Raymond Nagle, Daniel D. Von Hoff, David J. Bearss

Research output: Contribution to journalArticlepeer-review

81 Scopus citations

Fingerprint

Dive into the research topics of 'The mitotic serine threonine kinase, Aurora-2, is a potential target for drug development in human pancreatic cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences